21
total announcements
539551.BO · 15 min delayed
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced a Postal Ballot Notice to seek approval from members for a revision in professional fee payable to Dr. Varun Shetty as a Consultant Surgeon. The e-voting period will commence from September 5, 2026, and end on October 4, 2026.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has informed that the management will be meeting with FSSA Investment Managers on August 20, 2026, at 10:30 A.M. (IST) for a one-on-one meeting.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced the voting results and scrutinizer's report for the 26th Annual General Meeting held on August 14, 2026. The resolutions passed include the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the declaration of a dividend of Rs 4.50 per Equity Share.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd held its 26th Annual General Meeting on August 14, 2026, through Video Conferencing. The meeting was conducted in compliance with the General Circulars issued by the Ministry of Corporate Affairs and circulars issued by the Securities and Exchange Board of India. The Company Secretary informed the Members that the facility for shareholders to join the meeting through VC was made available, and live web-streaming of the meeting was done through the video conference facility provided by National Securities Depository Limited. The Annual Report and Notice of the 26th AGM were sent to shareholders via email, and physical copies were dispatched to those who requested them.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has released the transcript of its Q1 FY27 earnings call, discussing its domestic hospital business and revenue growth.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has informed the stock exchanges about a scheduled group investor meeting to be held on August 12, 2026, organized by Ambit Capital, where the company's management will meet representatives of various funds and institutions.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced a schedule for an investor meeting with ICICI Securities PMS on August 07, 2026, at 2:00 PM IST. The meeting is part of the company's compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced a schedule of a meeting with analysts and institutional investors on August 06, 2026, to discuss the company's performance and future prospects.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has uploaded the audio recording of its earnings call for the quarter ended June 30, 2026, on its website. The call was held on August 3, 2026, and the management answered queries related to the financial results and operations.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has released its revised investor presentation for the quarter ended June 30, 2026, highlighting its operational and financial performance for Q1 FY27. The company reported a 78.0% YoY increase in consolidated operating revenues to ₹ 26,836 Mn and a 18.8% EBITDA margin. Narayana Health has expanded its footprint with new facilities and services, including the launch of robotic surgery capabilities and a CUVIS Ortho Robotic System.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has published unaudited financial results for the quarter ended June 30, 2026, showing a net profit of ₹1,378.55 crore and a total income from continuing operations of ₹11,275.15 crore.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has released an investor presentation for the quarter ended June 30, 2026, highlighting its operational and financial performance. The company reported a consolidated operating revenue of ₹ 26,836 Mn, a change of +78.0% YoY and +3.5% QoQ, and a consolidated EBITDA of ₹ 5,052 Mn at a margin of 18.8%. The company also provided details on its revenue mix, patient footfalls, and ICU occupied bed days.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced its Q1 FY27 results, with consolidated operating revenue at ₹ 26,836 Mn, a YoY growth of 78.0%, and EBITDA of ₹ 5,052 Mn, a YoY growth of 40.0%. The company has also highlighted various achievements in its healthcare services, including 2,137 cardiac surgeries and the operationalization of new medical equipment.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹10,971.02 crore and ₹9,431.41 crore for the quarter and year ended March 31, 2026, respectively.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹10,971.02 crore, a 4.8% increase from ₹10,440.50 crore in the previous quarter.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has dispatched letters to shareholders with a weblink for accessing the Annual Report for FY 2025-26 and the Notice of the 26th Annual General Meeting.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd. will host a conference call on August 03, 2026, to discuss its performance for the quarter ended June 30, 2026.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has scheduled a board meeting on July 31, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has published a newspaper advertisement regarding the completion of electronic dispatch of the Annual Report for the financial year 2025-26 and the Notice of the 26th Annual General Meeting scheduled to be held on August 14, 2026.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd has announced the 26th Annual General Meeting (AGM) for FY 2025-26, scheduled to be held on August 14, 2026, through Video Conference. The meeting will consider and adopt the audited standalone and consolidated financial statements for FY 2025-26, along with the reports of the Board of Directors and Auditors. The company will also consider a final dividend of 4.50 per share and re-appoint Dr. Kiran Mazumdar Shaw as a Director.